AzTrials
AzTrials

PovertyPaycheckPlusNCT03226548

Effect of EITC on Biological Markers of Aging, Health and Mortality

A study testing Paycheck Plus in people with Poverty and Tax Policy, run by Columbia University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Poverty, Tax Policy
What is being tested?
Paycheck Plus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,350 participants
Where
1 siteUnited States
Study dates
20 Dec 2016to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • a US resident
  • Filed taxes
  • Earned <$30,000 in the previous year
  • Aged 21-64
  • Have a Social Security number

Who cannot join

  • Eligible for Supplemental Security Income or Social Security Disability Insurance
  • Married
  • Have dependent children

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Westat

    Atlanta, Georgia, 30303

Other trials in United States

About this study

Official title: An Experimental Investigation Into the Impact of Socioeconomic Context on Biological Markers of Aging, Health and Mortality

Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. EITC is politically popular, having received bipartisan support. The EITC, along with state supplemental programs, have 7 million American families out of poverty. The investigators' preliminary data analyses show that the EITC has had large population health impacts, reversing declines in self rated health and survival among the poorest Americans.

Read the detailed description

Poverty disproportionately impacts minority and rural populations and is very strongly correlated with poor health over the life cycle, and has been hypothesized to lead to a shorter, less healthy aging process. Poverty is associated with a greater burden of disease than smoking and obesity combined and accounts for the bulk of health disparities by race. It is widely believed that an antipoverty policy, such as Earned Income Tax Credit (EITC), could improve healthy aging among working-age low-income adults over the life cycle. It does so by increasing material hardship and psychological stress, two risk factors that are strongly correlated with biological markers of premature aging (e.g., shorter telomeres, higher cholesterol levels, and higher blood pressure).

Conditions
Poverty, Tax Policy
Being tested
Paycheck Plus
Keywords
Earned Income Tax Credit (EITC), Tax Credit, Paycheck Plus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Paycheck PlusOther

    A four-fold increase in the Earned Income Tax Credit

Study groups in NCT03226548
Study groupRoleWhat they receive
ExperimentalExperimentalPaycheck Plus: Participants will receive four times the standard Earned Income Tax Credit after filing their annual taxes
Receives: Other: Paycheck Plus
ControlNo interventionControl participants will receive the standard Earned Income Tax Credit after filing their annual taxes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Score on the Patient Health Questionnaire-9 (PHQ-9)

    Depression will be measured using the subject's score on the PHQ-9.

    Measured: 4 Years

  2. EuroQol 5D5L

    Health-related quality of life

    Measured: 4 years

Secondary outcomes (3)
  1. Mean Body Mass Index (BMI)

    A measure of obesity

    Measured: 2 Years

  2. Telomere length

    Telomere length is a measure of biological age

    Measured: 4 years

  3. Mortality

    We will link records to National Death Index for future study

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2017
  2. Study start20 Dec 2016
  3. Primary completion31 Dec 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,350 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03226548
Sponsor's protocol ID
AAAQ9663 (ADD-ON)
Other IDs
R01AG054466
Acronym
PaycheckPlus
Status last verified
Apr 2022
First submitted
18 Jul 2017
Last updated
6 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: To protect participant privacy we cannot share our data

Questions about this trial

What is this clinical trial studying?

A study testing Paycheck Plus in people with Poverty and Tax Policy, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Score on the Patient Health Questionnaire-9 (PHQ-9) (time frame: 4 Years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in